Clinical Scorecard: Computational Analysis of NS1 Antigenic Features in Dengue and Zika Viruses for Enhanced Diagnostic Precision

At a Glance

Key Highlights

• Dengue is the most prevalent arboviral infection with over 14 million cases reported in 2024.
• RT-PCR is the gold standard for DENV and ZIKV detection but has limitations.
• Lateral flow assays (LFA) show potential for rapid antigen detection despite cross-reactivity issues.
• Computational modeling can enhance diagnostic specificity for NS1 protein detection, improving clinical outcomes.
• Advancements in bioinformatics may improve the development of diagnostic tools.

Guideline-Based Recommendations

Diagnosis

• Utilize RT-PCR for accurate detection of DENV and ZIKV.
• Consider LFA for rapid antigen detection in resource-limited settings.
• Incorporate computational tools to enhance diagnostic accuracy.

Management

• Implement strategies to differentiate between DENV and ZIKV infections to avoid misdiagnosis.

Monitoring & Follow-up

• Regularly assess the performance of diagnostic tests in endemic regions.

Risks

• Cross-reactivity between DENV and ZIKV can lead to false-positive results.

Patient & Prescribing Data

Patients presenting with symptoms of arboviral infections in endemic areas.

Focus on accurate diagnostic methods to guide appropriate clinical management, ensuring timely and effective treatment.

Clinical Best Practices

• Employ advanced computational tools for structural analysis of viral proteins.
• Validate diagnostic tests against current circulating viral strains, using specific metrics for sensitivity and specificity.

Related Resources & Content

• NCBI Protein Database
• SWISS-MODEL
• AlphaFold